Acupuncture for Post-Stroke Dysphagia: A Clinical Study

ConditionsPost-stroke Dysphagia Acupuncture

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-80

SponsorFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine

About this trial

Employing a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different integrated Chinese and Western medicine treatment protocols. The nested partially randomized preference study of different acupuncture protocols generates high-level evidence through randomized cohorts while supplementing real-world decision-making with preference cohort data.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 80 years old, no gender restrictions;

Meets diagnostic criteria for ischemic or hemorrhagic stroke, confirmed by CT or MRI, with disease duration within one year;

Meets diagnostic criteria for dysphagia, with FOIS grade 2-4;

Vital signs stable, able to understand and cooperate with study procedures; ⑤ Patient or legal representative agrees to sign informed consent.

Disqualifiers

Dysphagia not caused by stroke, but resulting from other neurological disorders (e.g., motor neuron disease, myasthenia gravis) or organic lesions (e.g., tumors);

Patients with psychiatric disorders or severe cognitive impairment who cannot cooperate with treatment;

Patients with an expected survival time of less than 3 months; ④ Individuals with contrast medium allergy;

Patients with severe needle phobia who cannot tolerate the procedure; ⑥ Pregnant women, those planning pregnancy, or lactating women; ⑦ Individuals who have participated in other clinical trials or received acupuncture within the past week.

Trial design

Design model

Parallel

Treatments tested in this trial

acupuncture
Procedure/Surgery
Tongguan Liqiao Acupuncture Group： ①Acupoint Selection The treatment is phased, combining main and adjunct points. Main points: Neiguan (PC6), Shuigou (GV26), Sanyinjiao (SP6). Adjunct points: Fengchi (GB20), Wangu (GB12), Yifeng (TE17). Treatment is phased, combining primary and auxiliary points. ② Location and Operation Point locations follow the 2006 National Standard of the People's Republic of China (GB/T12346-2006) "Acupoint Names and Locations." Manipulation follows the SCM 88-2025 International Standard for Traditional Chinese Medicine Techniques: Acupuncture Method for Tongguan Liqiao to Treat Post-Stroke Dysphagia. Conventional Acupuncture Group： The "protocol scheme" habitually applied by each research unit (sub-center). Once designated, the protocol scheme shall not be altered and must be strictly adhered to.

Treatment groups

3,232 Participants

are divided into 2 treatment groups

Group A: "Tongguan Liqiao" Acupuncture GroupExperimental treatment 1 intervention

Group B: Conventional Acupuncture GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

Respondent proportion

Collect FOIS grading data at multiple time points. Proportion of patients showing an improvement of 2 grades or more in FOIS from baseline after treatment.

Time frame

Days 1-14

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Lead sponsor

Source ClinicalTrials.gov

Apply now